Caroline Wigerup

1.3k total citations · 1 hit paper
16 papers, 999 citations indexed

About

Caroline Wigerup is a scholar working on Cancer Research, Molecular Biology and Neurology. According to data from OpenAlex, Caroline Wigerup has authored 16 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Caroline Wigerup's work include Cancer, Hypoxia, and Metabolism (7 papers), Neuroblastoma Research and Treatments (7 papers) and Cancer Research and Treatments (3 papers). Caroline Wigerup is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Neuroblastoma Research and Treatments (7 papers) and Cancer Research and Treatments (3 papers). Caroline Wigerup collaborates with scholars based in Sweden, United Kingdom and Denmark. Caroline Wigerup's co-authors include Sven Påhlman, Daniel Bexell, Sofie Mohlin, Kristoffer von Stedingk, Annika Jögi, Esther Bridges, Kristina Aaltonen, Ingrid Hedenfalk, Noémie Braekeveldt and David Gisselsson and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Caroline Wigerup

16 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

2016 546 citations Caroline Wigerup, Sven Påhlman et al. Pharmacology & Therapeutics profile →

Peers

Caroline Wigerup

ONCOL

NEURO

PRM

Michael S. Nakazawa United States

Olivier Keunen Luxembourg

Jigisha P. Thakkar United States

Rolf Christofferson Sweden

Robert Lemos United States

Anh Tran United States

Fatima W. Khwaja United States

Yitian Chen China

Khalid Abubaker Australia

Michael S. Nakazawa United States

Caroline Wigerup

539 ×0.9

649 ×1.2

340 ×1.6

ONCOL

87 ×0.5

NEURO

271 ×2.3

PRM

Citations per year, relative to Caroline Wigerup Caroline Wigerup (= 1×) peers Michael S. Nakazawa

Countries citing papers authored by Caroline Wigerup

Since Specialization

Citations

This map shows the geographic impact of Caroline Wigerup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Wigerup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Wigerup more than expected).

Fields of papers citing papers by Caroline Wigerup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Wigerup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Wigerup. The network helps show where Caroline Wigerup may publish in the future.

Co-authorship network of co-authors of Caroline Wigerup

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Wigerup. A scholar is included among the top collaborators of Caroline Wigerup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Wigerup. Caroline Wigerup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Emdal, Kristina B., Nicolàs Palacio‐Escat, Caroline Wigerup, et al.. (2022). Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance. Cell Reports. 40(6). 111177–111177. 21 indexed citations

Persson, C., Kristoffer von Stedingk, Daniel Bexell, et al.. (2020). ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma. Experimental Cell Research. 388(2). 111845–111845. 24 indexed citations

Persson, C., Kristoffer von Stedingk, Daniel Bexell, et al.. (2017). Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum. Scientific Reports. 7(1). 10274–10274. 24 indexed citations

Mohlin, Sofie, Caroline Wigerup, Annika Jögi, & Sven Påhlman. (2017). Hypoxia, pseudohypoxia and cellular differentiation. Experimental Cell Research. 356(2). 192–196. 44 indexed citations

Wigerup, Caroline, Sven Påhlman, & Daniel Bexell. (2016). Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacology & Therapeutics. 164. 152–169. 546 indexed citations breakdown →

Braekeveldt, Noémie, Caroline Wigerup, Irene Tadeo, et al.. (2016). Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours. Cancer Letters. 375(2). 384–389. 27 indexed citations

Persson, C., Julhash U. Kazi, Lars Rönnstrand, et al.. (2016). HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells. Oncotarget. 7(10). 11238–11250. 19 indexed citations

Mohlin, Sofie, Kristoffer von Stedingk, Esther Bridges, et al.. (2015). PI3K–mTORC2 but not PI3K–mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma. Cancer Research. 75(21). 4617–4628. 76 indexed citations

Larsson, Anna-Maria, Caroline Wigerup, Jianmin Sun, et al.. (2014). EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation. Biochemical and Biophysical Research Communications. 445(1). 163–169. 17 indexed citations

10.

Braekeveldt, Noémie, Caroline Wigerup, David Gisselsson, et al.. (2014). Neuroblastoma patient‐derived orthotopic xenografts retain metastatic patterns and geno‐ and phenotypes of patient tumours. International Journal of Cancer. 136(5). E252–61. 62 indexed citations

11.

Larsson, Anna-Maria, Caroline Wigerup, Jianmin Sun, et al.. (2014). Abstract 3464: The effect of EPO-receptor in estrogen receptor positive breast cancer. Cancer Research. 74(19_Supplement). 3464–3464. 1 indexed citations

12.

Johansson, Ida, Kristina Aaltonen, Dorthe Grabau, et al.. (2011). Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis. Genes Chromosomes and Cancer. 51(4). 375–383. 29 indexed citations

13.

Mohlin, Sofie, Caroline Wigerup, & Sven Påhlman. (2011). Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage. Seminars in Cancer Biology. 21(4). 276–282. 27 indexed citations

14.

Aaltonen, Kristina, et al.. (2011). Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analyses. BMC Research Notes. 4(1). 69–69. 25 indexed citations

15.

Stendahl, Maria, Caroline Wigerup, Karin Jirström, et al.. (2010). p27^Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients. International Journal of Cancer. 127(12). 2851–2858. 24 indexed citations

16.

Ohshiro, Kazufumi, Suresh K. Rayala, Caroline Wigerup, et al.. (2010). Acetylation‐dependent oncogenic activity of metastasis‐associated protein 1 co‐regulator. EMBO Reports. 11(9). 691–697. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact